Capital Goods Healthcare Sector

Varex Imaging

Market Cap: US$332.5m

Designs, manufactures, and sells X-ray imaging components.

Anbio Biotechnology

Market Cap: US$330.9m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Cryoport

Market Cap: US$329.9m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

XOMA Royalty

Market Cap: US$328.9m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Olema Pharmaceuticals

Market Cap: US$328.4m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

American Oncology Network

Market Cap: US$326.6m

Through its subsidiaries, provides oncology management services in the United States.

Arcturus Therapeutics Holdings

Market Cap: US$325.2m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

iTeos Therapeutics

Market Cap: US$321.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

National Research

Market Cap: US$318.3m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Cresco Labs

Market Cap: CA$426.5m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

aTyr Pharma

Market Cap: US$306.2m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Pacific Biosciences of California

Market Cap: US$306.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Phathom Pharmaceuticals

Market Cap: US$305.8m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Abeona Therapeutics

Market Cap: US$302.4m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Aura Biosciences

Market Cap: US$297.6m

A clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors.

Heron Therapeutics

Market Cap: US$292.9m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Compass Therapeutics

Market Cap: US$291.8m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

EBR Systems

Market Cap: AU$453.0m

Develops implantable systems for wireless tissue stimulation.

Candel Therapeutics

Market Cap: US$285.6m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Aurora Cannabis

Market Cap: CA$393.0m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Entrada Therapeutics

Market Cap: US$282.4m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Neuronetics

Market Cap: US$282.4m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Immutep

Market Cap: AU$438.1m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Imricor Medical Systems

Market Cap: AU$435.8m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Neurogene

Market Cap: US$278.4m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

Healwell AI

Market Cap: CA$387.1m

A healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.

Sanara MedTech

Market Cap: US$277.1m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

Oceania Healthcare

Market Cap: NZ$463.5m

Owns and operates various care centers and retirement villages in New Zealand.

Terns Pharmaceuticals

Market Cap: US$275.1m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Panamera Holdings

Market Cap: US$273.1m

Does not have significant operations.

Health Catalyst

Market Cap: US$271.4m

Provides data and analytics technology and services to healthcare organizations in the United States.

Cartesian Therapeutics

Market Cap: US$269.1m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Oncology Institute

Market Cap: US$268.5m

An oncology company, provides various medical oncology services in the United States.

Viemed Healthcare

Market Cap: US$266.8m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

Alumis

Market Cap: US$265.5m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

Alpha Tau Medical

Market Cap: US$262.6m

A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.